Colby v. Assurant Employee Benefits

818 F. Supp. 2d 365, 2011 U.S. Dist. LEXIS 117751, 2011 WL 4840682
CourtDistrict Court, D. Massachusetts
DecidedOctober 12, 2011
DocketCivil Action No. 07-11488-WGY
StatusPublished
Cited by3 cases

This text of 818 F. Supp. 2d 365 (Colby v. Assurant Employee Benefits) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Colby v. Assurant Employee Benefits, 818 F. Supp. 2d 365, 2011 U.S. Dist. LEXIS 117751, 2011 WL 4840682 (D. Mass. 2011).

Opinion

MEMORANDUM

YOUNG, District Judge.

I. INTRODUCTION

This is an action under the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. §§ 1001-1461. Dr. Julie Colby (“Dr. Colby”) filed suit against the defendants, Assurant Employee Benefits, Fortis Benefits Insurance Company, Management Company for Merrimack Anesthesia Associates Long Term Disability Plan, and Union Security Insurance Company and Management Company for Merrimack Anesthesia Associates Long Term Disability Plan (collectively “USIC”), to recover long-term disability benefits (“LTD benefits”) allegedly denied to her by USIC in violation of 29 U.S.C. § 1132(a)(1)(B), as well as attorneys’ fees and costs.

In 2004, Dr. Colby, working as an anesthesiologist, began using Fentanyl, a [369]*369powerful opioid that she administered to patients, as a means of coping with severe back pain caused by a herniated disc and degenerative disc disease. Dr. Colby ultimately became addicted to the drug. After her coworkers discovered her addiction, Dr. Colby stopped working and voluntarily agreed not to practice medicine for six months. Her medical license was later suspended indefinitely. She enrolled in an inpatient substance abuse recovery program, and USIC provided her with LTD benefits under her policy (“the Plan”) for the duration of her rehabilitation. Upon her discharge, USIC terminated Dr. Colby’s benefits, claiming that she no longer had symptoms of active substance abuse. USIC justified the termination on the basis that “the potential for relapse [into substance abuse] is not the same as a current disability.” Admin. R. at US001957.1 In other words, USIC categorically excluded the risk of drug abuse relapse from qualifying impairments rendering an individual eligible for benefits under the Plan. After twice unsuccessfully appealing USIC’s determination and challenging its interpretation of the Plan, Dr. Colby initiated proceedings in this Court in 2007, claiming that USIC’s termination of her benefits was arbitrary and capricious.

The parties filed cross motions for summary judgment and agreed to resolve the dispute as a case stated. ECF Nos. 15, 20. This Court held that USIC had acted in an arbitrary and capricious manner, and remanded the case to USIC with instruction to consider Dr. Colby’s risk of drug abuse relapse as a long-term disability if the risk was found to be sufficiently high. USIC again denied Dr. Colby’s claim for relief and Dr. Colby appealed twice further, submitting additional evidence regarding her risk of drug abuse relapse. USIC denied both appeals, maintaining that the risk of drug abuse relapse was not a qualifying disability under the Plan. USIC also concluded that Dr. Colby’s condition could be mitigated by a reasonable accommodation, precluding the need for LTD benefits.

Dr. Colby instituted the present proceedings in 2009, reopening the administratively closed case. Both parties again have filed motions for summary judgment on the record and agreed to resolve the dispute as a case stated. “When deciding a ease stated, a court draws such inferences as are reasonable to resolve the case, rather than drawing all inferences against each moving party as it would when evaluating cross-motions for summary judgment.” Dickerson v. Prudential Life Ins. Co. of Am., 574 F.Supp.2d 239, 241 (D.Mass.2008) (citations omitted) (internal quotation marks omitted); see Bunch v. W.R. Grace & Co., 555 F.3d 1, 3 n. 4 (1st Cir.2009).

II. FACTS

The facts of the case prior to 2009 were presented in a more thorough fashion in Colby v. Assurant Employee Benefits (“Colby I”), 603 F.Supp.2d 223 (D.Mass.2009). The facts in this memorandum are slightly abridged, but contain the relevant history of the case up to the present.

A. Dr. Colby’s History of Back Issues, Substance Abuse, and Treatment

Dr. Colby became a partner at Merrimack Valley Anesthesia Associates in 1988 [370]*370and worked as a staff anesthesiologist at the Anna Jacques Hospital in Newburyport, Massachusetts. Admin. R. at US001405. Dr. Colby worked approximately sixty to ninety hours per week and was on call overnight two to three times per week. Id.

Dr. Colby began to experience back pain and numbness in her leg in the summer of 2000. Id. at US001406. She was diagnosed with a herniated disc and underwent a discectomy in September 2001. Id. at US001407. Her symptoms continued, however, and Dr. Colby was diagnosed with degenerative disc disease. Id. She began to self-medieate using Fentanyl, a powerful opioid administered during surgeries, taking the leftover narcotics from the operating room. Id. at US001408. Within a short time period, Dr. Colby became addicted to and dependent on Fentanyl. Id. at US001325. In July 2004, Dr. Colby was discovered asleep on a table in the hall of the hospital. Id. She submitted to a requested drug screen, tested positive for Fentanyl, and voluntarily agreed not to practice medicine for six months.2 Id. At the recommendation of Massachusetts Physician’s Health Services, Dr. Colby checked herself into the Talbott Recovery Campus in Atlanta, Georgia (“Talbott”), a facility that specializes in treating doctors with substance abuse problems. Id. at US002019-31. She remained a patient at Talbott from August 16, 2004, until November 20, 2004. Id.

In addition to opioid dependence, staff physicians at Talbott diagnosed Dr. Colby with dysthymic disorder, a history of major depressive disorder, and compulsive and avoidant personality traits. Id. at US002019-24. Dr. Colby was also provided with instruction on treating her back pain, which she rated a six out of ten on the Mankoski pain scale when she checked into Talbott. Id. at US002019-24. Dr. Colby engaged in a rigorous exercise program for two to three hours per day while at Talbott. By the time of her discharge, Dr. Colby’s back pain had reduced to a one or two out of ten on the Mankoski pain scale. Id. Dr. Colby’s mental health also improved, due to daily group meetings at which she discussed her addiction. Id. at US002020. Eventually, she received permission to stop taking the antidepressant drug, Zoloft, which she had been taking since 2003. Id.

Her discharge summary stated that she “explored the idea of returning to school and finding an area of medicine where she would not be exposed to her drug of choice.” Id. at US002023. Michael Wilkerson, M.D. (“Dr. Wilkerson”), the supervising physician at her intake and discharge examinations, nonetheless recommended “that she not return to the practice of medicine for six months to allow her to continue to work on her recovery and stabilize her home situation.” Id. at US002024.

B. Dr. Colby’s Application for LTD Benefits and USIC’s Subsequent Termination

Dr. Colby initially applied for LTD benefits under the Plan on September 24, 2004, while she was a patient at Talbott. Id. at US002270. Relying on an Attending Physician Statement and a Supplementary Attending Physician Report, both filed by Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
818 F. Supp. 2d 365, 2011 U.S. Dist. LEXIS 117751, 2011 WL 4840682, Counsel Stack Legal Research, https://law.counselstack.com/opinion/colby-v-assurant-employee-benefits-mad-2011.